Stockreport

United Therapeutics Corporation Announces Ralinepag Achieved 55% Reduction in Risk of Clinical Worsening in Pivotal Pulmonary Arterial Hypertension Study, Delivering Exceptional, Highly St...

United Therapeutics Corporation  (UTHR) 
Last united therapeutics corporation earnings: 4/29 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.unither.com/investor-relations
PDF clinical improvement by 47%, in predominantly pre-treated patients with pulmonary arterial hypertension ( PAH Ralinepag has the potential to redefine the PAH treatment [Read more]